logo-large
  • Browse Categories

Publications by authors named "David L Thacker"

Claim this Profile
C
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.
John J Lima, Cameron D Thomas, Julia Barbarino, Zeruesenay Desta, Sara L Van Driest, David L Thacker

Clin Pharmacol Ther· June 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Brief Background on Cannabis: From Plant to Medical Indications.
Linda E Klumpers, David L Thacker

J AOAC Int· March 2019


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is (+)-[13C]-pantoprazole better than (±)-[13C]-pantoprazole for the breath test to evaluate CYP2C19 enzyme activity?
David L Thacker, Anil Modak, David A Flockhart, Zeruesenay Desta

J Breath Res· March 2013


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereoselective pharmacokinetics of stable isotope (+/-)-[13C]-pantoprazole: Implications for a rapid screening phenotype test of CYP2C19 activity.
David L Thacker, Anil Modak, Phuong D Nguyen, David A Flockhart, Zeruesenay Desta

Chirality· November 2011


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: